Patent · US Active

Polymorph compositions, methods of making, and uses thereof

US9399019B2 · kind B2 · utility

0Cited by
18References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 13, 2013
Grant dateJul 26, 2016
Priority date
Expiry dateJul 14, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The described invention provides a biodegradable, biocompatible delivery system of flowable sustained release microparticulate composition of a substantially pure crystalline form of a bioactive agent such as, for example, nimodipine, a process of preparing a therapeutic form of a substantially pure crystalline form of the bioactive agent and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.